...
首页> 外文期刊>Journal of Clinical Microbiology >Prevalence of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, Brazil
【24h】

Prevalence of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, Brazil

机译:在巴西里约热内卢的陆军卫生局中,未接受过药物治疗的未感染个体中人类免疫缺陷病毒耐药突变和亚型的流行

获取原文
           

摘要

The prevalence of mutations that confer resistance to antiretroviral drugs was examined in 56 drug-naive, human immunodeficiency virus type 1 (HIV-1)-infected individuals from the Army Health Service in Rio de Janeiro, Brazil. No primary protease inhibitor mutations were found, but secondary mutations were observed in 51.2% of the samples. Fourteen percent of the viruses had reverse transcriptase inhibitor-associated mutations. Comparative analysis of protease secondary mutations from four different time periods in drug-naive patients in the city of Rio de Janeiro has indicated constant rates for particular mutations. Changes in CD4 cell counts and HIV viral load over time in subtype B- and non-B-infected drug-naive patients were not significantly different.
机译:在巴西里约热内卢的陆军卫生局,对56名未受过药物治疗的未感染人类1型人类免疫缺陷病毒(HIV-1)的个体进行了检测,这些突变对抗逆转录病毒药物具有耐药性。没有发现一级蛋白酶抑制剂突变,但在51.2%的样品中观察到二级突变。 14%的病毒具有逆转录酶抑制剂相关的突变。在里约热内卢市的一名未吸毒的患者中,来自四个不同时期的蛋白酶继发突变的比较分析表明,特定突变的发生率恒定。在未感染B型和未感染B型的未感染药物的亚型患者中,CD4细胞计数和HIV病毒载量随时间的变化没有显着差异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号